Midwest Ventures Group HCA MId America Division — Kansas City, Missouri

Midwest Ventures Group HCA MId America Division is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Midwest Ventures Group HCA MId America Division has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Endometrial Cancer.

Sponsors: Karyopharm Therapeutics Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Midwest Ventures Group HCA MId America Division?

Midwest Ventures Group HCA MId America Division has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Midwest Ventures Group HCA MId America Division conducted?

Midwest Ventures Group HCA MId America Division has 1 clinical trials on record, with 1 currently active. Their work covers Endometrial Cancer.

Is Midwest Ventures Group HCA MId America Division accredited by Crixeo Health?

Midwest Ventures Group HCA MId America Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Midwest Ventures Group HCA MId America Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.